Fundamental Analysis of MONOGRAM TECHNOLOGIES INC(NASDAQ:MGRM) stock

Fundamental Rating

Overall MGRM gets a fundamental rating of 3 out of 10. We evaluated MGRM against 191 industry peers in the Health Care Equipment & Supplies industry. MGRM has a great financial health rating, but its profitability evaluates not so good. MGRM is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year MGRM has reported negative net income.

In the past year MGRM has reported a negative cash flow from operations.

1.2 Ratios

MGRM has a worse Return On Assets (-119.17%) than 87.30% of its industry peers.

MGRM has a Return On Equity of -166.13%. This is in the lower half of the industry: MGRM underperforms 73.55% of its industry peers.

		Industry Rank	Sector Rank
ROA	-119.17%
ROE	-166.13%
ROIC	N/A

ROA(3y)-106.16%

ROA(5y)N/A

ROE(3y)-256.61%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

MGRM does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

MGRM does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for MGRM has been increased compared to 1 year ago.

There is no outstanding debt for MGRM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

MGRM has an Altman-Z score of 5.70. This indicates that MGRM is financially healthy and has little risk of bankruptcy at the moment.

With an excellent Altman-Z score value of 5.70, MGRM belongs to the best of the industry, outperforming 80.95% of the companies in the same industry.

There is no outstanding debt for MGRM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	5.7

ROIC/WACCN/A

WACC9.43%

2.3 Liquidity

A Current Ratio of 3.28 indicates that MGRM has no problem at all paying its short term obligations.

MGRM has a Current ratio of 3.28. This is comparable to the rest of the industry: MGRM outperforms 58.20% of its industry peers.

A Quick Ratio of 3.28 indicates that MGRM has no problem at all paying its short term obligations.

The Quick ratio of MGRM (3.28) is better than 69.31% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	3.28
Quick Ratio	3.28

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for MGRM have decreased strongly by -31.06% in the last year.

EPS 1Y (TTM)-31.06%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%37.73%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

MGRM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.99% yearly.

The Revenue is expected to grow by 212.72% on average over the next years. This is a very strong growth

EPS Next Y18.52%

EPS Next 2Y11.13%

EPS Next 3Y17.18%

EPS Next 5Y15.99%

Revenue Next Year-100%

Revenue Next 2Y181.24%

Revenue Next 3Y287.62%

Revenue Next 5Y212.72%

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

MGRM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MGRM. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

MGRM's earnings are expected to grow with 17.18% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y11.13%

EPS Next 3Y17.18%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for MGRM!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

MONOGRAM TECHNOLOGIES INC

NASDAQ:MGRM (1/14/2025, 8:00:01 PM)

2.47

+0.02 (+0.82%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)11-14 2024-11-14/amc

Earnings (Next)N/A N/A

Inst Owners1.67%

Inst Owner Change0%

Ins Owners23.83%

Ins Owner Change3.71%

Market Cap84.75M

Analysts82.86

Price Target5.1 (106.48%)

Short Float %0.58%

Short Ratio1.34

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-4.85%

Min EPS beat(2)-19.83%

Max EPS beat(2)10.13%

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-16.67%

PT rev (3m)-16.67%

EPS NQ rev (1m)0%

EPS NQ rev (3m)0%

EPS NY rev (1m)-8.89%

EPS NY rev (3m)-8.89%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	232.18
P/FCF	N/A
P/OCF	N/A
P/B	12.03
P/tB	12.84
EV/EBITDA	N/A

EPS(TTM)-0.37

EYN/A

EPS(NY)-0.47

Fwd EYN/A

FCF(TTM)-0.33

FCFYN/A

OCF(TTM)-0.33

OCFYN/A

SpS0.01

BVpS0.21

TBVpS0.19

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-119.17%
ROE	-166.13%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-106.16%

ROA(5y)N/A

ROE(3y)-256.61%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score5

Asset Turnover0.04

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	8.54%
Cap/Sales	9.95%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	3.28
Quick Ratio	3.28
Altman-Z	5.7

F-Score5

WACC9.43%

ROIC/WACCN/A

Cap/Depr(3y)130.2%

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-31.06%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%37.73%

EPS Next Y18.52%

EPS Next 2Y11.13%

EPS Next 3Y17.18%

EPS Next 5Y15.99%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next Year-100%

Revenue Next 2Y181.24%

Revenue Next 3Y287.62%

Revenue Next 5Y212.72%

EBIT growth 1Y-62.7%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year18.51%

EBIT Next 3Y18.62%

EBIT Next 5Y18.14%

FCF growth 1Y-15.41%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-15.39%

OCF growth 3YN/A

OCF growth 5YN/A

MONOGRAM TECHNOLOGIES INC (MGRM)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens